Biodesix acquires Seattle-based developer of blood-based lung nodule test
Acquisition of Integrated Diagnostics gives Biodesix control of test to determine if nodules are benign or malignant.
Integrated Diagnostics
Acquisition of Integrated Diagnostics gives Biodesix control of test to determine if nodules are benign or malignant.